Literature DB >> 6109747

The effect of histamine on epidermal outgrowth: its possible dual role as an inhibitor and stimulator.

T Aoyagi, K Adachi, K M Halprin, V Levine, C W Woodyard.   

Abstract

We have investigated the effect of histamine on pig epidermal cell outgrowths in vitro. Histamine inhibited the epidermal cell outgrowths (and also mitosis). This inhibition was partially counteracted by a specific H2 antagonist, cimetidine. Inhibition was maximal at a histamine concentration of 10(-4) M and was less at 10(-3) M. These histamine concentrations respectively coincide with the optimal concentrations for accumulating intracellular cyclic AMP (via H2 receptors) and cyclic GMP (via H1 receptors) in the same pig epidermal slice system. 4-Methyl-histamine, a pure H2 agonist, which only increased the intracellular cyclic AMP level but not the cyclic GMP level, caused a maximal outgrowth inhibition at 10(-3) M. Attempts to counteract the histamine effects due to cyclic GMP accumulation by various H1 antagonists (so that 10(-3) M histamine would have caused maximal outgrowth inhibition) were unsuccessful, since the addition of each H1 antagonist alone strongly inhibited the outgrowth. These data strongly suggest a dual role of histamine through the cyclic nucleotide system; i.e., histamine inhibits epidermal cell growth by elevating the intracellular cyclic AMP level via an H2 receptor, while histamine at high concentrations (10(-3) M) partially counteracts the inhibition by increasing cyclic GMP via an H1 receptor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109747     DOI: 10.1111/1523-1747.ep12524488

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  2 in total

1.  Histamine catabolism in proliferating skin.

Authors:  W A Fogel; M Swiderska; C Maslinski
Journal:  Agents Actions       Date:  1989-04

2.  Increased epidermal filaggrin in chronic idiopathic urticaria is associated with severity of urticaria.

Authors:  Young-Min Ye; Byung Eui Kim; Yoo-Seob Shin; Hae-Sim Park; Donald Y M Leung
Journal:  Ann Allergy Asthma Immunol       Date:  2014-04-13       Impact factor: 6.347

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.